Specify a stock or a cryptocurrency in the search bar to get a summary
Guizhou Yibai Pharmaceutical Co Ltd
600594Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, pills, and oral solutions in the areas of tumor system, cerebrovascular, respiratory system, rheumatism, digestive system, pediatric, gynecological, anti-infection, anti-inflammatory, analgesic, and other diseases. The company was founded in 1995 and is based in Guiyang, China. Address: No. 220-1, Baiyun Avenue, Guiyang, China, 550008
Analytics
WallStreet Target Price
47.34 CNYP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 600594
Dividend Analytics 600594
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
125 %Dividend History 600594
Stock Valuation 600594
Financials 600594
Results | 2019 | Dynamics |